
A non-human primate model explores the association between hyperglycemia and long COVID symptoms using SARS-CoV-2-infected African green monkeys. Early-onset hyperglycemia and immunometabolic changes resembling human COVID-19 outcomes were observed. The Pfizer/BioNTech vaccine aided in glycemic control, suggesting potential benefits in the acute phase. The model provides insights into COVID-19-related metabolic pathologies.
Like
Save
Share